We are live on ! Find out more
TCP

Tyndall Capital Partners Portfolio holdings

AUM $452K
1-Year Est. Return 26.52%
This Fund
S&P 500
This Quarter Est. Return
-41.55%
1 Year Est. Return
+26.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.84M
AUM Growth
Cap. Flow
+$2.31M
Cap. Flow %
125.41%
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 78.8%
2 Miscellaneous 21.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRAW icon
1
Traws Pharma
TRAW
$9M
$1.45M 78.8%
+93
New +$1.9M
ONTXW
2
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
$391K 21.2%
+390,624
New +$413K

Similar funds

Tyndall Capital Partners's Q3 2016 Portfolio in Review

Q3 2016 is the first quarter with a 13F filing on record for Tyndall Capital Partners, which disclosed 2 positions worth $1.84M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Traws Pharma: 93 shares worth $1.45M.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, followed by Miscellaneous.

  • Tyndall Capital Partners's largest Q3 2016 buy was Traws Pharma: 93 shares worth $1.45M.
  • Tyndall Capital Partners's ten largest holdings make up 100% of its $1.84M portfolio in Q3 2016.
  • Tyndall Capital Partners disclosed 2 positions in Q3 2016, its first 13F filing on record.

Based on Tyndall Capital Partners's 13F filing for Q3 2016, filed 14 Nov 2016.